Literature DB >> 218883

Malignant fibrous histiocytoma of bone: a study of 35 cases.

E F McCarthy, T Matsuno, H D Dorfman.   

Abstract

Thirty-five cases of primary malignant fibrous histiocytoma of bone are reported. Twenty of these cases were collected from a retrospective analysis of other malignant bone tumors. The age range was from 11 to 69 years; the average age was 34 years. The tumor occurred most commonly in the distal femur and proximal tibia. The distinguishing histologic feature was a storiform arrangement of spindle cells. The differential diagnosis included fibrosarcoma, osteogenic sarcoma, malignant giant cell tumor, malignant lymphoma, and metastatic carcinoma. Follow-up of at least three years was available in 21 cases. Of these, nine patients were alive and free of metastases three and one-half to 12 years after treatment. Two were alive with solitary metastases at three years, and 10 patients died between three months and three years after treatment. In four cases the lesions were multicentric at the time of diagnosis and in four cases were associated with bone infarction. This tumor must be recognized as an important complication of bone infarction and should be suspected when a patient with a known history of bone infarction develops a change in symptoms. Because the prognosis of this tumor is significantly better than that in those tumors with which it had been previously grouped, and in view of its association with bone infarction, it deserves to be maintained as a distinct clinicopathologic entity. Amputation is the treatment of choice.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218883     DOI: 10.1016/s0046-8177(79)80072-6

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  Case report 639: Malignant fibrous histiocytoma (MFH) of the patella.

Authors:  F López-Barea; J L Rodríguez-Peralto; E Burgos-Lizalde; J González-López; S Sánchez-Herrera
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

2.  Chronic knee pain in an 80-year-old woman.

Authors:  Mark R Robbin; Peter G Pavlidakey; Patrick Getty; Hooman Yarmohammadi
Journal:  Clin Orthop Relat Res       Date:  2013-06-28       Impact factor: 4.176

3.  Malignant fibrous histiocytoma of the pericranium: case report.

Authors:  P Dyck
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

4.  Case report 408: Malignant fibrous histiocytoma of innominate bones and femur (multicentric).

Authors:  M Castillo; J Tehranzadeh; J Becerra; W Mnaymneh
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

Review 5.  Malignant fibrous histiocytoma of the distal femur after an arthroscopic anterior cruciate ligament reconstruction: A case report and a review of the literature.

Authors:  Turgay Efe; Thomas J Heyse; Markus D Schofer; Susanne Fuchs-Winkelmann; Peter Rexin; Jan Schmitt
Journal:  BMC Cancer       Date:  2010-06-08       Impact factor: 4.430

Review 6.  The rare primary bone sarcomas: imaging-pathological correlation.

Authors:  Rupert Berkeley; Vanghelita Andrei; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-01-07       Impact factor: 2.199

7.  Dedifferentiated chondrosarcoma of humerus with giant cell tumor-like features.

Authors:  T Ishida; H D Dorfman; E T Habermann
Journal:  Skeletal Radiol       Date:  1995-01       Impact factor: 2.199

8.  Fibrosarcoma and malignant fibrous histiocytoma of long bones: radiographic features and grading.

Authors:  W K Taconis; J D Mulder
Journal:  Skeletal Radiol       Date:  1984       Impact factor: 2.199

9.  Fibrous histiocytoma (fibroxanthoma) of a cervical vertebra. A report with a review of the literature.

Authors:  J M Destouet; M Kyriakos; L A Gilula
Journal:  Skeletal Radiol       Date:  1980       Impact factor: 2.199

Review 10.  Primary leiomyosarcoma of bone. A clinical, radiographic, pathologic-anatomic, and prognostic study of 16 cases.

Authors:  O Berlin; L Angervall; L G Kindblom; I C Berlin; B Stener
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.